# Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression

> **NCT06124417** · PHASE4 · COMPLETED · sponsor: **First Affiliated Hospital of Chongqing Medical University** · enrollment: 125 (actual)

## Conditions studied

- Efficacy, Team
- Adverse Reaction to Drug

## Interventions

- **DRUG:** Sertraline

## Key facts

- **NCT ID:** NCT06124417
- **Lead sponsor:** First Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-10
- **Primary completion:** 2023-08-25
- **Final completion:** 2023-09-29
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06124417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06124417, "Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06124417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*